Yumanity Therapeutics, Inc. (YMTX) Annual Margin Report - Discounting Cash Flows
YMTX
Yumanity Therapeutics, Inc.
YMTX (NASDAQ)

Annual Margin Analysis Report

Margins refer to the ratio between a financial report item and the revenue (Example: Net Income Margin = Net Income / Revenue).

This analysis provides a report of the company's key margins, which could be further used in a valuation model.

Interactive Assumptions

Historical Years

Historical Years

Number of historical years used to render the Chart and Tables.

Margin Analysis (% of Revenue)

Monetary values in USD

Monetary values in USD

amounts except #

Average LTM
Jan 09
2024
Dec 31
Revenue
0 0
Revenue Growth Rate
Cost of Revenue
0 0
Gross Profit
0 0
Gross Margin
Operating Income -7.78 -2.02 -13.53
Operating Margin
Net Income -9.4 -1.68 -17.13
Net Margin

Monetary values in USD

amounts except #

Average LTM
Jan 09
2024
Dec 31
Revenue
0 0
Cash From Operating Activities Margin
Cash From Operating Activities -11.57
-11.57
Free Cash Flow Margin
Free Cash Flow -11.57
-11.57
Depreciation and Amortization Margin
Depreciation and Amortization
0
Capital Expenditure Margin
Capital Expenditure
0
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program